San Diego, CA, United States of America

Alexa Kollmeier

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Janssen Research & Development, LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexa Kollmeier. Retrieved from https://idiyas.com/inventor/alexa-kollmeier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alexa Kollmeier: Inventor in Biopharmaceutical Research.

Introduction

Alexa Kollmeier is an inventor associated with Janssen Research & Development, LLC, in San Diego, California. Her patent work concerns treatment approaches for psoriatic arthritis.

Latest Patents

Kollmeier is named on 1 patent: “Method of Treating Psoriatic Arthritis Patients with Inadequate Response to TNF Therapy with Anti-IL23 Specific Antibody.” The patent describes using an anti-IL-23-specific antibody for patients whose psoriatic arthritis has not responded adequately to TNF therapy.

Career Highlights

Her listed patent reflects work in biopharmaceutical research and the development of treatment methods for inflammatory disease. The available information identifies Janssen Research & Development, LLC, as her company.

Collaborations

Kollmeier’s listed coworkers include Jaime Oliver Vigueras and May Shawi. Their names appear alongside her in connection with the patent information provided.

Conclusion

Alexa Kollmeier’s patent activity highlights her contribution to research on treatment options for psoriatic arthritis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…